EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Performance of Chimeric Recombinant Antigens of Trypanosoma cruzi for Identifying Chagas Disease in Samples From Rio Grande do Sul

Ângelo Antônio Oliveira Silva iD, Ítalo Ferreira de Leon iD, Felipe Silva Santos de Jesus iD, Daniel Dias Sampaio iD, André Luis Bartz Voigt iD, Natália Berne Pinheiro iD, Nathieli Bianchin Bottari iD, Leda Margarita Castaño-Barrios iD, Paola Alejandra Fiorani Celedon iD, Nilson Ivo Tonin Zanchin iD, Fabricio Klerynton Marchini iD, Maria Elisabeth Aires Berne iD und 1 weitere

Tropical Medicine & International Health · 2025

DOI: 10.1111/tmi.70019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2025. Verfasst von Ângelo Antônio Oliveira Silva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Health Public Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Antigens, Protozoan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chagas disease, caused by Trypanosoma cruzi , remains a significant public health challenge in Latin America, with diagnostic limitations hindering control efforts.

Aim

Our study aimed to assess the diagnostic performance of four chimeric recombinant T. cruzi antigens (IBMP‐8.1, IBMP‐8.2, IBMP‐8.3 and IBMP‐8.4) in a highly endemic region in southern Brazil.

Methods

Serum samples from 333 individuals residing in Canguçu, Rio Grande do Sul, were tested using an in‐house ELISA platform. We assessed the sensitivity, specificity, accuracy, and diagnostic odds ratio (DOR) of individual and combined IBMP antigens through serial and parallel testing strategies.

Results

All antigens exhibited 100% specificity and high accuracy (≥ 93.4%), with IBMP‐8.1 and IBMP‐8.4 showing the best overall performance (sensitivities of 80.0% and 76.7%; DORs of 109,136 and 89,659, respectively). Parallel testing using the combinations IBMP‐8.1 + IBMP‐8.3 and IBMP‐8.1 + IBMP‐8.4 achieved ≥ 95% sensitivity and > 99% accuracy.

Conclusions

These findings support the use of IBMP chimeric antigens, particularly in combination, as reliable tools for Chagas disease diagnosis and surveillance, and highlight the importance of region‐specific validation to ensure diagnostic equity in diverse endemic settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseTrypanosoma cruziAntigens, ProtozoanHumansBrazilSensitivity and SpecificityEnzyme-Linked Immunosorbent AssayMaleFemaleAdultRecombinant ProteinsAntibodies, ProtozoanMiddle AgedAdolescentYoung Adult

Stichwörter der Autor:innen

Trypanosoma cruziELISAchimeric recombinant antigensserological diagnosis

Substanzen

Antigens, ProtozoanRecombinant ProteinsAntibodies, Protozoan

Autor:innen und Institutionen

  • Advanced Health Public Laboratory, Goncalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
  • Interdisciplinary Research Group in Biotechnology and Epidemiology of Infectious Diseases (GRUPIBE), Goncalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.
  • Laboratory for Parasitology, Postgraduate Program in Microbiology and Parasitology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
  • Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil.
  • Structural Biology and Protein Engineering Laboratory, Carlos Chagas Institute, Oswaldo Cruz Foundation, Curitiba, Paraná, Brazil.
  • Integrated Translational Program in Chagas Disease From Fiocruz-Fio-Chagas, Vice Presidency of Research and Biological Collections, Oswaldo Cruz Fountation, Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Ângelo Antônio Oliveira Silva, Ítalo Ferreira de Leon, Felipe Silva Santos de Jesus, Daniel Dias Sampaio, André Luis Bartz Voigt, Natália Berne Pinheiro, Nathieli Bianchin Bottari, Leda Margarita Castaño-Barrios, Paola Alejandra Fiorani Celedon, Nilson Ivo Tonin Zanchin, Fabricio Klerynton Marchini, Maria Elisabeth Aires Berne, Fred Luciano Neves Santos

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Silva, Â. A. O., de Leon, Í. F., de Jesus, F. S. S., Sampaio, D. D., Voigt, A. L. B., Pinheiro, N. B., Bottari, N. B., Castaño-Barrios, L. M., Celedon, P. A. F., Zanchin, N. I. T., Marchini, F. K., Berne, M. E. A., & Santos, F. L. N. (2025). Diagnostic Performance of Chimeric Recombinant Antigens of Trypanosoma cruzi for Identifying Chagas Disease in Samples From Rio Grande do Sul. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70019

Vancouver

Silva ÂAO, de Leon ÍF, de Jesus FSS, Sampaio DD, Voigt ALB, Pinheiro NB, et al. Diagnostic Performance of Chimeric Recombinant Antigens of Trypanosoma cruzi for Identifying Chagas Disease in Samples From Rio Grande do Sul. Tropical Medicine & International Health. 2025. doi:10.1111/tmi.70019

BibTeX
@article{Silva2025,
  author = {Silva, Ângelo Antônio Oliveira and de Leon, Ítalo Ferreira and de Jesus, Felipe Silva Santos and Sampaio, Daniel Dias and Voigt, André Luis Bartz and Pinheiro, Natália Berne and Bottari, Nathieli Bianchin and Castaño-Barrios, Leda Margarita and Celedon, Paola Alejandra Fiorani and Zanchin, Nilson Ivo Tonin and Marchini, Fabricio Klerynton and Berne, Maria Elisabeth Aires and Santos, Fred Luciano Neves},
  title = {Diagnostic Performance of Chimeric Recombinant Antigens of Trypanosoma cruzi for Identifying Chagas Disease in Samples From Rio Grande do Sul},
  journal = {Tropical Medicine & International Health},
  year = {2025},
  doi = {10.1111/tmi.70019}
}
Kostenlos starten →